Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 7Head & Neck 2Gastrointestinal 2Other solid neoplasm 1Gynecologic 1Breast 1

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Re-Irradiation × Gastrointestinal × Clear all
NCT05984576 2023-08-09

RETRY

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
88 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02745847 2023-05-25

Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer

Changhai Hospital

Phase NA Unknown
30 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡